The Rationale of Applying Inspiratory/expiratory Muscle Training Within the Same Respiratory Cycle in Children with Bronchial Asthma: a Placebo-controlled Randomized Clinical Investigation
Overview
Pulmonary Medicine
Affiliations
Objective: Even though positive implications of inspiratory muscle training (In-MT) have been established in children and adolescents with bronchial asthma (C/AwBA), the role of combined inspiratory and expiratory muscle training (Ex-MT) within the same respiratory cycle (In/Ex-SC) is still unknown. This study was, therefore, set out to explore the effect of In/Ex-SC on respiratory muscle strength, pulmonary functions, and control of asthma symptoms in C/AwBA.
Methods: This was a placebo-controlled randomized clinical investigation that included 51 C/AwBA (12-18 years). Participants were assigned randomly into three groups: Placebo, In-MT only, or combined In/Ex-SC training ( = 17, each group). The training was conducted for ∼35 min, thrice/week over 12 weeks. The maximal inspiratory (IP) and expiratory (EP) pressure (indicating the strength of the inspiratory and expiratory muscles, respectively), pulmonary functions [forced expiratory volume in one second (FEV), forced vital capacity (FVC), and FEV/FVC index], and asthma control test (ACT) were assessed before and after the intervention.
Results: The In/Ex-SC yielded larger increases in IP and EP than either the Placebo training (=.031 and =.009 respectively) or the In-MT (=.029 and =.032 respectively). Further, In/Ex-SC produced favorable improvement in FEV, FVC, and FEV/FVC compared to the Placebo training (=.001, =.004, and =.0005 respectively) or In-MT (=.038, =.037, and =.025 respectively) training. Furthermore, In/Ex-SC led to better control of asthma symptoms than the Placebo (<.001) or In-MT (=.002) training.
Conclusion: This study provides evidence that combined In/Ex-SC can considerably improve respiratory muscle strength, enhance pulmonary function, and promote control over asthma symptoms in C/AwBA.
Lin L, Li S, Liu Q, Zhang X, Xiong Y, Zhao S Front Microbiol. 2025; 15():1492783.
PMID: 39831118 PMC: 11739148. DOI: 10.3389/fmicb.2024.1492783.
Elnaggar R, Osailan A, Alghadier M, Elnegamy T, Morsy W, Abdrabo M Medicine (Baltimore). 2024; 103(48):e40667.
PMID: 39612435 PMC: 11608701. DOI: 10.1097/MD.0000000000040667.
Wu P, Qian X, Hu Y, Yan X J Asthma Allergy. 2024; 17:1073-1082.
PMID: 39493893 PMC: 11531299. DOI: 10.2147/JAA.S479398.
Wu P, Hu Y, Yan X J Asthma Allergy. 2024; 17:743-750.
PMID: 39131601 PMC: 11317056. DOI: 10.2147/JAA.S475367.
Xiang Y, Luo T, Chen X, Zhang H, Zeng L Front Pediatr. 2024; 12:1367710.
PMID: 38562138 PMC: 10982517. DOI: 10.3389/fped.2024.1367710.